Contact
Please use this form to send email to PR contact of this press release:
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMLX
TO: